This week, it was revealed that Hal Barron (a well-respected US scientist) would move to Altos Labs. He will be leaving GlaxoSmithKline after five years of service with the drugmaker.
This 59-year old will be the new head of the San Francisco-based company, which is focused on biology and cellular renewal programming with the goal of reverseing diseases.
Cellular programming has been proven to rejuvenate cells and may hold the key to preventing and fighting off diseases such as cancer and Alzheimer’s, both of which are linked with aging.
Yuri Milner and Jeff Bezos, the founder of Amazon. Barron will move to the start-up which received $3 billion of funding in August.
‘Milestone’ surgery sees pig kidneys transplanted into human
After the earlier funding announcement, billionaire-backed firms are currently hiring.
It was founded in America and the UK in 2012. The company has offices in Silicon Valley, San Diego, California and Cambridge, England.
Barron will continue to serve as an executive director on the GSK board for three more years.
His departure comes at an era of increased pressure on the drugmaker. Elliott Management, an activist hedge fund based in New York, advised the company to increase its share price and operational performance.
This story can be shared on social media